1. Home
  2. CRDL vs GOAI Comparison

CRDL vs GOAI Comparison

Compare CRDL & GOAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cardiol Therapeutics Inc.

CRDL

Cardiol Therapeutics Inc.

HOLD

Current Price

$1.31

Market Cap

154.1M

Sector

Health Care

ML Signal

HOLD

GOAI

Eva Live Inc. Common Stock

N/A

Current Price

$3.73

Market Cap

150.5M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
CRDL
GOAI
Founded
2017
2015
Country
Canada
United States
Employees
N/A
3
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Computer Software: Programming Data Processing
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
154.1M
150.5M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
CRDL
GOAI
Price
$1.31
$3.73
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$8.50
N/A
AVG Volume (30 Days)
653.6K
59.1K
Earning Date
05-14-2026
04-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$18.31
Revenue Growth
N/A
N/A
52 Week Low
$0.88
$2.75
52 Week High
$1.71
$6.67

Technical Indicators

Market Signals
Indicator
CRDL
GOAI
Relative Strength Index (RSI) 49.10 43.75
Support Level $0.95 $3.48
Resistance Level $1.43 $4.36
Average True Range (ATR) 0.10 0.35
MACD -0.02 -0.02
Stochastic Oscillator 12.50 13.75

Price Performance

Historical Comparison
CRDL
GOAI

About CRDL Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc is a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease. Its primary small-molecule candidate, CardiolRx, targets inflammasome pathway activation, which is involved in the development of inflammation and fibrosis in conditions such as pericarditis, myocarditis, and heart failure. The CardiolRx program includes the completed Phase II MAVERIC-Pilot study and the ongoing Phase III MAVERIC trial for the treatment of pericarditis. The ARCHER program evaluated CardiolRx in acute myocarditis through a completed Phase II study. The company is also developing CRD-38, a novel subcutaneous drug formulation for treating inflammatory heart conditions, including heart failure.

About GOAI Eva Live Inc. Common Stock

Eva Live Inc is a United States-based technology company that has developed an automated and intelligent advertiser campaign management platform, Eva Platform, which enables advertisers ('customers, clients') to buy advertising space on several digital channels to reach their desired audience. The company also works with Businesses that utilize its in-house digital marketing capabilities, including advice, creative services, account management, production of advertising materials, media planning, and buying.

Share on Social Networks: